Metaplastic breast carcinoma
the importance of anatomopathologic confirmation
Keywords:
Breast neoplasms, Triple negative breast neoplasms, MetaplasiaAbstract
Objective: To compare the initial diagnosis, usually from community pathology services, with the final pathology report from certified pathology service. Methods: A retrospective analysis of patients in an institution with final diagnosis of metaplastic breast cancer (MBC) was conducted from January 2008 to January 2014. Results: There were 18 female patients diagnosed with MBC. Median age was 49.8 years old; 52.9% of the patients had a tumor size less than 3.0 cm; 72.2% had no axillary lymphadenopathy at diagnosis. None of them had distant metastases at presentation. Initial diagnosis of invasive ductal carcinoma (IDC) occurred in 60% of patients. Eighty percent of patients were treated with neo-adjuvant chemotherapy and presented progression. Only one case with diagnosis of MBC prior to therapy was submitted to neo-adjuvant chemotherapy with a platinum-based regimen and presented clinical response. Conclusion: Due to the triple-negative histopathology features, MBC might have been underdiagnosed in community pathology services. In cases of non-response or progression of the disease regarding the traditional treatment, MBC diagnosis should be considered and the medical report must be reviewed.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.